LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
US Stock MarketDetailed Quotes
GILD Gilead Sciences
- 114.310
- +2.320+2.07%
Close Feb 28 16:00 ET
- 114.200
- -0.110-0.10%
Post 20:01 ET
142.43BMarket Cap300.82P/E (TTM)
114.770High111.810Low12.60MVolume112.150Open111.990Pre Close1.43BTurnover1.01%Turnover Ratio300.82P/E (Static)1.25BShares114.77052wk High7.40P/B142.15BFloat Cap60.24352wk Low3.08Dividend TTM1.24BShs Float114.770Historical High2.69%Div YieldTTM2.64%Amplitude0.402Historical Low113.849Avg Price1Lot Size
Gilead Sciences Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 35.27%10.83B | 37.33%2.98B | 145.39%4.31B | -43.35%1.32B | 27.16%2.22B | -11.76%8.01B | -15.58%2.17B | -38.67%1.76B | 29.69%2.34B | -5.16%1.75B |
| Net income from continuing operations | -91.45%480M | 25.83%1.78B | -42.31%1.25B | 55.34%1.61B | -523.35%-4.17B | 22.93%5.61B | -13.23%1.42B | 21.61%2.17B | -8.46%1.04B | 8,108.33%985M |
| Operating gains losses | 64.07%274M | 166.67%126M | -252.07%-257M | 666.67%391M | -94.53%14M | -74.58%167M | -409.84%-189M | -14.21%169M | -122.77%-69M | 166.67%256M |
| Depreciation and amortization | 2.75%2.77B | 0.73%693M | 0.88%690M | 1.91%694M | 7.81%690M | 28.06%2.69B | 30.30%688M | 30.29%684M | 29.71%681M | 21.90%640M |
| Deferred tax | -91.68%-1.84B | -2.43%-379M | -747.06%-576M | 24.89%-166M | -138.61%-723M | 38.02%-962M | -9.47%-370M | 74.81%-68M | 24.57%-221M | 53.46%-303M |
| Other non cash items | 153.08%5.02B | -94.86%47M | 307.59%591M | -66.23%128M | 682.69%4.25B | 14.97%1.98B | 133.42%915M | -74.74%145M | -33.27%379M | 185.79%543M |
| Change In working capital | 61.79%-880M | 188.95%483M | 141.45%642M | -567.07%-1.55B | 15.31%-459M | -30.63%-2.3B | -564.10%-543M | -1,223.93%-1.55B | 155.07%331M | 53.36%-542M |
| -Change in receivables | -11.46%139M | -67.27%72M | 126.47%162M | 66.28%-29M | -110.39%-66M | 138.67%157M | 178.29%220M | -64.52%-612M | 80.97%-86M | -9.16%635M |
| -Change in inventory | 49.41%-426M | 26.38%-226M | -3.66%-85M | 69.03%-70M | 80.18%-45M | -171.61%-842M | -11.23%-307M | 13.68%-82M | -2,925.00%-226M | -528.30%-227M |
| -Change in prepaid assets | -764.10%-259M | -356.25%-146M | -1,240.00%-57M | -147.50%-19M | -242.31%-37M | 129.10%39M | 50.77%-32M | -58.33%5M | 248.15%40M | 148.15%26M |
| -Change in payables and accrued expense | 258.56%398M | -9.85%247M | 2,333.33%511M | -140.73%-257M | 87.36%-103M | 120.22%111M | -55.81%274M | -90.87%21M | 80.80%631M | 53.38%-815M |
| -Change in other working capital | 58.60%-732M | 176.79%536M | 112.60%111M | -4,082.14%-1.17B | -29.19%-208M | -385.71%-1.77B | -686.55%-698M | -915.74%-881M | 94.15%-28M | -43.75%-161M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 35.25%10.83B | 37.16%2.98B | 145.53%4.31B | -43.33%1.33B | 27.24%2.22B | -11.75%8.01B | -15.50%2.17B | -38.70%1.76B | 29.74%2.34B | -5.22%1.74B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -52.21%-3.45B | 68.96%-226M | -209.61%-709M | 36.02%-309M | -166.95%-2.21B | 8.11%-2.27B | -94.13%-728M | 67.88%-229M | -56.82%-483M | 22.80%-826M |
| Capital expenditure reported | 10.60%-523M | 31.63%-147M | -15.57%-141M | 6.47%-130M | 3.67%-105M | 19.64%-585M | -18.78%-215M | 22.29%-122M | 2.80%-139M | 55.87%-109M |
| Net business purchase and sale | -320.14%-4.84B | 73.12%-75M | -621.52%-570M | 37.45%-152M | -633.76%-4.04B | 35.89%-1.15B | -27.98%-279M | 82.37%-79M | 25.00%-243M | 31.72%-551M |
| Net investment purchase and sale | 451.52%1.86B | 83.26%-39M | 73.53%-9M | 66.00%-34M | 1,303.73%1.94B | -980.00%-528M | -1,159.09%-233M | 67.92%-34M | -162.50%-100M | -906.25%-161M |
| Net other investing changes | --58M | --36M | --10M | 1,000.00%9M | 160.00%3M | ---- | ---- | ---- | ---1M | ---5M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -52.27%-3.45B | 69.05%-225M | -210.04%-710M | 36.44%-307M | -167.19%-2.21B | 8.15%-2.27B | -93.87%-727M | 67.88%-229M | -56.82%-483M | 22.80%-826M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 33.03%-3.43B | 305.45%2.26B | 9.22%-1.38B | -168.55%-2.95B | 3.34%-1.36B | 20.76%-5.13B | 29.21%-1.1B | 28.28%-1.52B | -9.67%-1.1B | 21.57%-1.41B |
| Net issuance payments of debt | 653.33%1.49B | 345,600.00%3.46B | 58.67%-112M | ---- | ---- | 82.00%-270M | --1M | 72.90%-271M | ---- | ---- |
| Net common stock issuance | 5.21%-728M | -42.74%-177M | 6.91%-202M | 23.39%-95M | 16.17%-254M | 29.35%-768M | 79.87%-124M | -50.69%-217M | -79.71%-124M | -17.44%-303M |
| Cash dividends paid | -2.86%-3.92B | -3.18%-973M | -3.15%-983M | -2.97%-972M | -2.17%-990M | -2.70%-3.81B | -3.06%-943M | -2.58%-953M | -2.61%-944M | -2.54%-969M |
| Net other financing activities | -1.08%-281M | -42.42%-47M | -5.13%-82M | -6.06%-35M | 12.69%-117M | -60.69%-278M | -43.48%-33M | -73.33%-78M | -135.71%-33M | -47.25%-134M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 33.01%-3.43B | 305.64%2.26B | 9.22%-1.38B | -168.21%-2.95B | 3.20%-1.36B | 20.78%-5.13B | 29.28%-1.1B | 28.28%-1.52B | -9.77%-1.1B | 21.63%-1.41B |
| Net cash flow | ||||||||||
| Beginning cash position | 12.44%6.09B | -11.71%5.04B | -51.40%2.77B | -4.42%4.72B | 12.44%6.09B | 1.39%5.41B | 21.41%5.71B | 20.36%5.7B | 14.90%4.94B | 1.39%5.41B |
| Current changes in cash | 540.58%3.95B | 1,360.35%5.01B | 31,628.57%2.22B | -356.29%-1.94B | -175.87%-1.35B | 349.64%616M | -46.24%343M | -78.13%7M | 53.77%755M | 52.25%-489M |
| Effect of exchange rate changes | -170.18%-40M | -248.65%-55M | 833.33%44M | -184.62%-11M | -238.46%-18M | 190.48%57M | -50.67%37M | 91.67%-6M | 127.08%13M | 172.22%13M |
| End cash Position | 64.19%9.99B | 64.19%9.99B | -11.71%5.04B | -51.40%2.77B | -4.42%4.72B | 12.44%6.09B | 12.44%6.09B | 21.41%5.71B | 20.36%5.7B | 14.90%4.94B |
| Free cash flow | 38.86%10.31B | 44.73%2.83B | 155.24%4.17B | -45.66%1.2B | 29.30%2.11B | -11.06%7.42B | -18.11%1.95B | -39.65%1.63B | 32.55%2.2B | 2.64%1.64B |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Trending Stocks
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call